Clinical trial
Historical Control Study of Refractory IFI or Patients Intolerant to Standard…
NCT00230243 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00230243 |
|---|---|
| Title | Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387) |
| Official title | A Retrospective Study to Establish an Historical Database on the Efficacy of Standard Antifungal Therapy in Patients With Invasive Fungal Infections |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Infection, Invasive Fungal |
| Enrollment | 330 |
| Start date | Mar 1, 1997 |
| Primary completion | Sep 1, 2002 |
| Completion | Sep 1, 2002 |
| First posted | Sep 30, 2005 |
| Last update posted | Mar 10, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: